Future single-cell RNA-Seq (scRNA-Seq) profiling of NB spheroids treated with BMX inhibitors will help delineate how different cell types within the same spheroid may transition to a NOR state or decrease their proliferation and viability. The gene discussed is BMX; the disease is neuroblastoma.